Kroeger Christopher A.
SEC CIK 1658918 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | CEO, Dir | 1.27M | — | $12.54M | 10 | 2025-10-27 | 2026-08-17 |
Most active insiders at MPLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalyst4, Inc. | 10% | $157.89M | — |
| 2 | Novo Holdings A/S | 10% | $16.20M | — |
| 3 | Kroeger Christopher A. | CEO, Dir | — | $12.54M |
| 4 | GILLIS JONATHAN | CAO, Interim CFO | — | $3.56M |
| 5 | Foff Erin Pennock | Chief Medical Off | — | $3.38M |
| 6 | Kreitzer Anatol | Chief Discovery Off | — | $2.78M |
| 7 | Lillie James Woodruff | CSO | — | $2.56M |
| 8 | Hanson Kristopher | GC | — | $1.66M |
| 9 | Malenka Robert C. | Dir | — | $1.60M |
| 10 | Setia Vishwas | CFO | — | $1.10M |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-19 18:35 | 2026-08-17 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | A - Grant | $0.00 | +23.1K | 1.27M | +2% | $0 |
| M | 2026-07-17 21:46 | 2026-07-15+ | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | S - Sale | $36.87 | -147.6K | 1.25M | -11% | -$5.44M |
| MT | 2026-05-18 21:27 | 2026-05-18 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | S - Sale | $27.19 | -118.2K | 1.39M | -8% | -$3.21M |
| MT | 2026-05-11 21:30 | 2026-05-07+ | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | S - Sale | $28.47 | -68.5K | 1.51M | -4% | -$1.95M |
| MT | 2026-05-06 20:15 | 2026-05-04+ | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | S - Sale | $28.39 | -49.7K | 1.58M | -3% | -$1.41M |
| M | 2026-04-17 16:05 | 2026-04-15+ | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | S - Sale | $27.16 | -19.2K | 1.63M | -1% | -$521.1K |
| D | 2026-02-09 | 2026-02-05 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | A - Grant | $0.00 | +23.1K | 1.65M | +1% | $0 |
| 2026-01-29 | 2026-01-27 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | F - Tax | $17.98 | -204.1K | 1.63M | -11% | -$3.67M | |
| D | 2025-10-28 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | C - Cnv Deriv | — | +3,895 | 229.6K | +2% | — |
| D | 2025-10-28 | 2025-10-27 | MPLT | MapLight Therapeutics, Inc. | Kroeger Christopher A. | CEO, Dir | A - Grant | $0.00 | +225.7K | 225.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations